Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cimoli

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Carcinogenesis|November 1, 1994
Induction of DNA double-strand breaks by 8-methoxycaffeine: cell cycle dependence and comparison with topoisomerase II inhibitorsP Russo, G Cimoli, M Valenti, et al.
Mutation Research|November 1, 1995
Interferon-alpha or beta potentiate platinum analogous in human glioblastoma cell linesS Stanzione, G Cimoli, D Debernardis, et al.
Anticancer Research|July 1, 1995
Sensitization of human glioblastoma T98G cells to VP16 and VM26 by human tumor necrosis factorP Morgavi, G Cimoli, C Ottoboni, et al.
Cytokine|April 1, 1996
Tumour necrosis factor enhances the therapeutic effect of mitoxantrone in human ovarian cancer xenograftE Noviello, G Cimoli, A Cosimi, et al.
Japanese Journal of Cancer Research : Gann|November 1, 1991
Human granulocyte-macrophage colony-stimulating factor is a growth factor active on human ovarian cancer cellsG Cimoli, P Russo, G Billi, et al.
Biochemical Pharmacology|October 5, 1993
Potentiation of TNF-mediated cell killing by mitoxantrone. Relationship to DNA single-strand break formationM Valenti, G Cimoli, G L Mariani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Potentiation of tumour necrosis factor-mediated cell killing by VP16 on human ovarian cancer cell lines. In vitro results and clinical implicationsM Valenti, G Cimoli, S Parodi, et al.
Oncology Research|January 1, 1993
Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3G Cimoli, M Valenti, S Parodi, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
"Atypical" multidrug resistance in human ovarian cancer cell line A2780 selected for resistance to doxorubicin (A2780 DX3)G Cimoli, M Valenti, E Noviello, et al.
Chemosphere|December 5, 1998
Biological effects of a neurotoxic pesticide at low concentrations on sea urchin early development. A terathogenic assayA Morale, L Coniglio, C Angelini, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Carcinogenesis|November 1, 1994
Induction of DNA double-strand breaks by 8-methoxycaffeine: cell cycle dependence and comparison with topoisomerase II inhibitorsP Russo, G Cimoli, M Valenti, et al.
Mutation Research|November 1, 1995
Interferon-alpha or beta potentiate platinum analogous in human glioblastoma cell linesS Stanzione, G Cimoli, D Debernardis, et al.
Anticancer Research|July 1, 1995
Sensitization of human glioblastoma T98G cells to VP16 and VM26 by human tumor necrosis factorP Morgavi, G Cimoli, C Ottoboni, et al.
Cytokine|April 1, 1996
Tumour necrosis factor enhances the therapeutic effect of mitoxantrone in human ovarian cancer xenograftE Noviello, G Cimoli, A Cosimi, et al.
Japanese Journal of Cancer Research : Gann|November 1, 1991
Human granulocyte-macrophage colony-stimulating factor is a growth factor active on human ovarian cancer cellsG Cimoli, P Russo, G Billi, et al.
Biochemical Pharmacology|October 5, 1993
Potentiation of TNF-mediated cell killing by mitoxantrone. Relationship to DNA single-strand break formationM Valenti, G Cimoli, G L Mariani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Potentiation of tumour necrosis factor-mediated cell killing by VP16 on human ovarian cancer cell lines. In vitro results and clinical implicationsM Valenti, G Cimoli, S Parodi, et al.
Oncology Research|January 1, 1993
Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3G Cimoli, M Valenti, S Parodi, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
"Atypical" multidrug resistance in human ovarian cancer cell line A2780 selected for resistance to doxorubicin (A2780 DX3)G Cimoli, M Valenti, E Noviello, et al.
Chemosphere|December 5, 1998
Biological effects of a neurotoxic pesticide at low concentrations on sea urchin early development. A terathogenic assayA Morale, L Coniglio, C Angelini, et al.
Pageof 3